Tiverton Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,147
| Closed | -$577K | – | 713 |
|
|
2019
Q2 | $577K | Sell |
1,147
-393
| -26% | -$198K | 0.02% | 351 |
|
|
2019
Q1 | $1.53M | Sell |
1,540
-1,499
| -49% | -$1.49M | 0.07% | 195 |
|
|
2018
Q4 | $2.64M | Sell |
3,039
-1,087
| -26% | -$944K | 0.16% | 110 |
|
|
2018
Q3 | $4.27M | Buy |
4,126
+633
| +18% | +$654K | 0.21% | 94 |
|
|
2018
Q2 | $3.21M | Sell |
3,493
-16
| -0.5% | -$14.7K | 0.16% | 109 |
|
|
2018
Q1 | $3.42M | Buy |
3,509
+2,831
| +418% | +$2.76M | 0.24% | 94 |
|
|
2017
Q4 | $306K | Sell |
678
-449
| -40% | -$203K | 0.02% | 304 |
|
|
2017
Q3 | $466K | Sell |
1,127
-138
| -11% | -$57.1K | 0.03% | 166 |
|
|
2017
Q2 | $443K | Sell |
1,265
-427
| -25% | -$150K | 0.02% | 172 |
|
|
2017
Q1 | $869K | Hold |
1,692
| – | – | 0.04% | 167 |
|
|
2016
Q4 | $600K | Sell |
1,692
-1,527
| -47% | -$541K | 0.04% | 179 |
|
|
2016
Q3 | $1.72M | Sell |
3,219
-4,936
| -61% | -$2.64M | 0.14% | 133 |
|
|
2016
Q2 | $6.75M | Buy |
8,155
+1,351
| +20% | +$1.12M | 0.28% | 97 |
|
|
2016
Q1 | $3.24M | Sell |
6,804
-601
| -8% | -$286K | 0.11% | 124 |
|
|
2015
Q4 | $4.89M | Hold |
7,405
| – | – | 0.16% | 112 |
|
|
2015
Q3 | $5.82M | Sell |
7,405
-1,600
| -18% | -$1.26M | 0.13% | 115 |
|
|
2015
Q2 | $11.9M | Buy |
9,005
+1,405
| +18% | +$1.85M | 0.24% | 100 |
|
|
2015
Q1 | $7.9M | Buy |
7,600
+3,600
| +90% | +$3.74M | 0.16% | 112 |
|
|
2014
Q4 | $2.68M | Buy |
+4,000
| New | +$2.68M | 0.06% | 127 |
|